Creative. Innovative. Professional.
Entomus is a new wave of pharmaceutical Development. Combining pharmaceutical consulting and participation in Development, Entomus undertakes the scientific and marketing strategies, as well as full managing of your project.
Realizing commercial ideas from a practical point of view, Entomus can become your long-term partner in the pharmaceutical business.
Realizing commercial ideas from a practical point of view, Entomus can become your long-term partner in the pharmaceutical business.
Introduction
Introduction
Entomus is a pharmaceutical company, which was established in 2020 by the decision of a group of specialists with more than 25 years of experience in pharmaceutical business.
The company's specialists and partners work in many areas of pharmaceuticals, carry out scientific and business development.
The company's specialists and partners work in many areas of pharmaceuticals, carry out scientific and business development.
Entomus is
Own projects
Rational thinking
Fast management
Market recognizability
Pharmaceutical consulting
Scientific assistance
Development
Development
Now more detailed. Entomus considers today the following as the highest priority:
Synthesis, Development and Technical Transfer of highly-potent & highly-toxic API Technologies for Anticancer Drugs
Development & Technology Transfer of Orally Dispersible Films (ODFs)
New Drug Delivery System for oncological compounds based on recombinant H-Ferritin.
Development of Complex final formulation for injectable and oral applications.
Development of Biocatalytic Processes Applicable for API Manufacturing.
Biotechnological process for recombinant proteins based on different expression systems.
Development and Technological Transfer of Steroid Hormones including Photochemical Synthetic Processes.
Collaboration
Collaboration
Our team
Also learn more about our team
Angelo Colombo
Has more than thirty years of experience in the pharmaceutical field, gained both in the context of multinationals such as Pfizer, Schering-Plough, Pharmacia, and in important CDMOs like Corden Pharma. He has covered the role of Chairman, CEO and board member in pharmaceutical companies in the last years. He holds a degree in Chemistry and Pharmaceutical Technologies obtained at the University of Milan
Dr. Thomas Beckert
Dr. Thomas Beckert is a German pharmaceutical expert specializing in thin-film drug delivery systems. He is the founder and managing director of Vektor Pharma GmbH, that focuses on the development of transdermal therapeutic systems and other film-based dosage forms. He completed his pharmaceutical state examination at the University of Freiburg in 1991 and became a Ph.D. in Pharmacy from the University of Tübingen. His expertise includes formulation and machine development for transdermal and oral dissolvable therapeutic systems, as well as auditing pharmaceutical suppliers globally.
Oleksandr Zabudkin
Former medical oncologist with more than 25 years of experience in API branch of pharmaceutical industry: founder of Synbias Pharma Ltd. Main field of activity: management of new projects, API pharmaceutical facilities including fermentative processes, highly potent and highly toxic synthetic and semi-synthetic processes and final formulations pharmaceutical facilities including sterile filling of highly toxic compounds. Participation in GMP implementation at 3 manufacturing sites is also under belt.
Plavnicka 560, 373 81 Kamenny Ujezd, Czech Republic
ID in Trade Register of Czech Republic (IČO): 09311254
VAT-Number (DIČ): CZ09311254
Fill out the form and we will contact you
Please, don't forget: our common dreams can become our common reality
© Entomus s.r.o. 2020, All rights reserved
Bank details:
FIO BANKA a.s. Senovážné nám. 24, 116 47 Nové Město, Prague, Czech Republic
IBAN:
CZ3420100000002201844284
BIC/SWIFT:
FIOBCZPPXXX
Back to the top
Fill out the form and we will contact you
Please, don't forget: our common dreams can become our common reality
